retatrutide ly3437943 phase 2 trial obesity nejm 2023 triple agonist Another Promising Medication (Retatrutide) for Triple–Hormone-Receptor Agonist Retatrutide for Obesity – forevervital FDA approval for Zepbound Collagen Flavor:Chocolate

retatrutide ly3437943 phase 2 trial obesity nejm 2023 triple agonist Another Promising Medication (Retatrutide) for Triple–Hormone-Receptor Agonist Retatrutide for Obesity – forevervital FDA approval for Zepbound Collagen Flavor:Chocolate

FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly - Medical Update Online

Retatrutide’s unique molecular structure enables potent activation of GLP-1, GIP, and glucagon receptors, leading to significant weight reduction, improved glycemic control, and favorable metabolic outcomes

forevervital

Collagen Flavor:Chocolate

Endocrinology 159, 665–675